CERS

Cerus Corporation (CERS) is a pioneering biomedical products company focused on improving blood safety through its groundbreaking INTERCEPT Blood System, designed to inactivate pathogens in blood components. Headquartered in Concord, California, Cerus employs state-of-the-art technology to meet the critical demands of transfusion medicine, ensuring enhanced patient safety. With a robust and expanding portfolio, the company is strategically positioned to capitalize on the global need for safe blood products, aiming to advance blood safety protocols and contribute significantly to public health.